Tobramycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 39822-0412

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 39822-0412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Heading (Tobramycin For Injection Usp 1)

Tobramycin injection powder label panel indicating a pharmacy bulk package of 1.2 g strength, lyophilized for solution, not for direct infusion, and for intravenous use. The label includes an Rx only symbol and is from XGen Pharmaceuticals DJB, Inc.*

FDA Label Image

C:\documents And Settings\junem.x-gen\desktop\spl Submissions\tobramycin Spl\fda Style Sheet\01.jpg (Tobramycin For Injection Usp 2)

Chemical structure of the active ingredient Tobramycin, shown as a molecular diagram with multiple amino and hydroxyl groups in a complex ring system.*

FDA Label Image

Table 3 (Tobramycin For Injection Usp 3)

A dosage schedule guide table for Tobramycin Injection, USP in adults with normal renal function, showing dosing at 8-hour intervals. It lists patient weights in kg and lb, usual dose for serious infections (1 mg/kg q8h), and maximum dose for life-threatening infections (1.66 mg/kg q8h), with corresponding mg/dose and mL/dose values. A footnote indicates applicability except for pediatric formulation Tobramycin Injection, USP, 10 mg/mL.*

FDA Label Image

C:\documents And Settings\junem.x-gen\desktop\spl Submissions\tobramycin Spl\fda Style Sheet\02.jpg (Tobramycin For Injection Usp 4)

A reduced dosage nomogram chart showing the relationship between serum creatinine levels (mg/100 mL) on the x-axis and percent of normal dosage from Table 1 on the y-axis. It includes creatinine clearance adjusted for body surface area (mL/min/1.73 m²) along the top axis to assist in dosage calculations.*

FDA Label Image

Tobr-vl-02 (Tobramycin For Injection Usp 5)

Tobramycin 1.2 g/30mL injection, powder, lyophilized, for solution, intravenous use. The label contains details including the proprietary and generic names, route, and manufacturer XGen Pharmaceuticals DJB, Inc. The packaging primarily uses white and purple colors with the label text in black.*

FDA Label Image

Tobr-cs-03 (Tobramycin For Injection Usp 6)

FDA Label Image

Tobr-cm-02 (Tobramycin For Injection Usp 7)

Label for Tobramycin for Injection, USP 1.2 grams Per Pharmacy Bulk Package, lyophilized powder for intravenous solution. The label states it is a pharmacy bulk package, not for direct infusion, and is labeled for intravenous use. It is distributed by XGen Pharmaceuticals DJB, Inc. The label includes preparation instructions, storage conditions, and handling information.*

FDA Label Image

Tobramycin For Injection Usp 8

Tobramycin for Injection, USP 1.2 gm lyophilized powder label by XGen Pharmaceuticals DJB, Inc. The label indicates it is a pharmacy bulk package not for direct infusion, for intravenous use only. It includes storage instructions, preparation of solution details, and highlights the product contains no preservative. NDC 39822-0412-1 is shown on the label.*

FDA Label Image

Tobramycin For Injection Usp 9

Label for Tobramycin for Injection, USP 1.2 gm, a powder for solution, intravenous use. This is a pharmacy bulk package labeled 'NOT FOR DIRECT INFUSION' from XGen Pharmaceuticals DJB, Inc. The label includes storage instructions, preparation directions, and notes that each vial contains tobramycin sulfate equivalent to 1200 mg of tobramycin. The package is a Six-Pak of 6 vials with NDC 39822-0412-6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.